Allergan Grabs Liver Disease Drugmaker In Up-To-$1.7B Deal
Allergan PLC is set to buy clinical-stage biopharmaceutical company Tobira Therapeutics Inc. after agreeing Tuesday to a deal that could be worth up to $1.7 billion, giving the pharmaceutical giant access...To view the full article, register now.
Already a subscriber? Click here to view full article